The OraQuick HCV Rapid Antibody Test Approved by the FDA
Share
Follow Us
FDA Approves Rapid Test for Antibodies to Hepatitis C Virus
SILVER SPRING, Md., June 25 /PRNewswire-USNewswire/ — The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older.
The OraQuick HCV Rapid Antibody Test is used to test individuals who are at risk for infection with HCV and people with signs or symptoms of hepatitis. HCV is transmitted through exposure to infected blood, which, for example, can occur during intravenous drug use. The virus can also be transferred from an infected mother to her child. Hepatitis C can lead to liver inflammation and dysfunction and, over time, to liver disease and liver cancer.
OraQuick is a test strip and does not require an instrument for diagnosis. It takes about 20 minutes to obtain results from the test.
Continue reading this entire article:
http://www.prnewswire.com/news-releases/fda-approves-rapid-test-for-antibodies-to-hepatitis-c-virus-97162349.html
